fda status of bpc-157 2023 2024 When will the reclassify to Category 1? Odds & Predictions The FDA will hold a

10.2147/ott.S113353 Oncol

Through accelerated testing and long-term sample retention observation, the degradation of the product under high temperature and high humidity conditions is evaluated to ensure the stability of its quality within the validity period

notably, the proportion of patients with weight gain during the study was substantially higher in the placebo group

It is not a drug, food, cosmetic, or dietary supplement, and is not for human or veterinary use, ingestion, or diagnostic application

Signs of vitamin B6 deficiency include dermatitis (skin inflammation), glossitis (a sore tongue), depression, confusion and convulsions